Research News

Antiplatelet agents for adults with chronic kidney disease?

BMJ 2013; 346 doi: (Published 06 March 2013) Cite this as: BMJ 2013;346:f1392


Antiplatelet agents do not prevent deaths from cardiovascular disease or any other cause in adults with chronic kidney disease. In the first comprehensive meta-analysis in this patient group, drugs such as aspirin and clopidogrel reduced the risk of …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial